مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

647
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

601
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EVALUATION OF FLUTICASONE (FLIXONASE) NASAL SPRAY VERSUS BECLOMETHASONE (BECONASE) NASAL SPRAY IN THE TREATMENT OF ALLERGIC RHINITIS

Pages

  193-196

Abstract

 Although response to intranasal steroid therapy has been reported in patients with ALLERGIC RHINITIS, efficacy of some nasal steroids is noteworthy. This study was undertaken to evaluate the efficacy of a two-week course of Fluticasone (Flixonase) NASAL SPRAY vs. Beclomethasone (beconase) NASAL SPRAY in patients with symptoms of ALLERGIC RHINITIS referred to our clinic. This study reviewed sixty randomized studies with symptoms of ALLERGIC RHINITIS which supported common aeroallergens with skin prick test. Patients received a total daily dose of NASAL SPRAY of Fluticasone (Flixonase) 100 mcg bid (N=30) compared with patients with ALLERGIC RHINITIS who received a total daily dose of Beclomethasone (Beconase) 50mcg 2 puffs bid (N=30). Patients were visited before and after therapy, and efficacy of Flixonase and Beconase was evaluated by the change in nasal symptoms including: nasal discharge, nasal obstruction, nasal itching, and sneezing. After two weeks of TREATMENT nasal symptoms of blockage, discharge, sneezing and itching were significantly better in the group treated with Fluticasone NASAL SPRAY (65%, 82%, 67%, 79% respectively (p<0.001) but after TREATMENT with beconase NASAL SPRAY lower benefits in the nasal symptoms includes: 50%, 71%, 51%, 57% respectively. After two weeks of TREATMENT no deleterious changes consequent to therapy were observed in nasal symptoms. 100 mcg bid Flixonase (Fluticasone) intranasal spray is more effective than 50 mcg 2 puffs bid Beconase (Beclomethasone) intranasal spray. Like asthma, ALLERGIC RHINITIS is an inflammatory disease and should be managed with anti-inflammatory medication.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    FARID, R., FARID, F., GHAFFARI, J., JABARI, FARHAD, & RAHIM ZADEH, M.. (2003). EVALUATION OF FLUTICASONE (FLIXONASE) NASAL SPRAY VERSUS BECLOMETHASONE (BECONASE) NASAL SPRAY IN THE TREATMENT OF ALLERGIC RHINITIS. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), 2(4), 193-196. SID. https://sid.ir/paper/291051/en

    Vancouver: Copy

    FARID R., FARID F., GHAFFARI J., JABARI FARHAD, RAHIM ZADEH M.. EVALUATION OF FLUTICASONE (FLIXONASE) NASAL SPRAY VERSUS BECLOMETHASONE (BECONASE) NASAL SPRAY IN THE TREATMENT OF ALLERGIC RHINITIS. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI)[Internet]. 2003;2(4):193-196. Available from: https://sid.ir/paper/291051/en

    IEEE: Copy

    R. FARID, F. FARID, J. GHAFFARI, FARHAD JABARI, and M. RAHIM ZADEH, “EVALUATION OF FLUTICASONE (FLIXONASE) NASAL SPRAY VERSUS BECLOMETHASONE (BECONASE) NASAL SPRAY IN THE TREATMENT OF ALLERGIC RHINITIS,” IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), vol. 2, no. 4, pp. 193–196, 2003, [Online]. Available: https://sid.ir/paper/291051/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button